These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24091316)

  • 21. Effects of smoking and blood eosinophil count on the development of arteriovenous fistulae thrombosis in hemodialysis patients.
    Ozdemir FN; Akcay A; Bilgic A; Akgul A; Arat Z; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2918-21. PubMed ID: 16213261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients.
    Lin CC; Chang CF; Lai MY; Chen TW; Lee PC; Yang WC
    J Am Soc Nephrol; 2007 Mar; 18(3):985-92. PubMed ID: 17267744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers of vascular calcification and mortality in patients with ESRD.
    Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of blood flow in hemodialysis patients using buttonhole technique for arteriovenous fistula by ultrasound dilution.
    Krairittichai U; Leetrakulpanich B
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S62-8. PubMed ID: 22619889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients.
    Kirkpantur A; Arici M; Altun B; Yilmaz MI; Cil B; Aki T; Bakkaloglu M; Turgan C
    Blood Purif; 2008; 26(4):322-32. PubMed ID: 18487877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular access outcomes in the elderly hemodialysis population: A USRDS study.
    Chan MR; Sanchez RJ; Young HN; Yevzlin AS
    Semin Dial; 2007; 20(6):606-10. PubMed ID: 17991212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis.
    Ozkaya O; Buyan N; Bideci A; Gonen S; Ortac E; Fidan K; Cinaz P; Söylemezoğlu O
    Nephron Clin Pract; 2007; 105(4):c153-8. PubMed ID: 17259742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil-lymphocyte ratio (NLR) in chronic hemodialysis patients.
    Yilmaz H; Bozkurt A; Cakmak M; Celik HT; Bilgic MA; Bavbek N; Akcay A
    Ren Fail; 2014 Oct; 36(9):1390-4. PubMed ID: 25246339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of far infrared therapy on arteriovenous fistula maturation: an open-label randomized controlled trial.
    Lin CC; Yang WC; Chen MC; Liu WS; Yang CY; Lee PC
    Am J Kidney Dis; 2013 Aug; 62(2):304-11. PubMed ID: 23474008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and functional effect of arteriovenous fistula calcifications, evaluated by spiral CT in chronic haemodialysis patients].
    Roca-Tey R; Páez R; Rivas A; Samon R; Ibrik O; Giménez I; Viladoms J
    Nefrologia; 2009; 29(3):214-21. PubMed ID: 19554054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function.
    Collado S; Coll E; Nicolau C; Azqueta M; Pons M; Cruzado JM; de la Torre B; Deulofeu R; Mojal S; Pascual J; Cases A
    BMC Nephrol; 2017 Sep; 18(1):290. PubMed ID: 28882110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
    Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
    Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arteriovenous fistula use and heart disease in long-term elderly hemodialysis patients: analysis of United States Renal Data System Dialysis Morbidity and Mortality Wave II.
    Abbott KC; Trespalacios FC; Agodoa LY
    J Nephrol; 2003; 16(6):822-30. PubMed ID: 14736009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients.
    Nishiura R; Fujimoto S; Sato Y; Yamada K; Hisanaga S; Hara S; Nakao H; Kitamura K
    Am J Nephrol; 2009; 29(3):257-63. PubMed ID: 18802328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of arteriovenous fistula function by the temperature gradient method using the Twister™ device.
    Roca-Tey R; Samon R; Ibrik O; Roda A; González-Oliva JC; Viladoms J
    Nefrologia; 2012; 32(2):172-9. PubMed ID: 22425797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of Osteopontin as a Marker of Arteriovenous Shunt Stenosis in Hemodialysis Patients.
    Elbarbary MR; Ahmed LA; El-Adl DA; Ezzat AA; Nassib SA
    Curr Vasc Pharmacol; 2024; 22(1):50-57. PubMed ID: 38038003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
    Kurnatowska I; Grzelak P; Kaczmarska M; Stefańczyk L; Nowicki M
    Nephron Clin Pract; 2011; 117(4):c297-304. PubMed ID: 20861651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.
    Mikami S; Hamano T; Fujii N; Nagasawa Y; Isaka Y; Moriyama T; Matsuhisa M; Ito T; Imai E; Hori M
    Hypertens Res; 2008 Jun; 31(6):1163-70. PubMed ID: 18716364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
    Chrysis D; Efthymiadou A; Mermigka A; Kritikou D; Spiliotis BE
    Pediatr Diabetes; 2017 Jun; 18(4):277-282. PubMed ID: 27028343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
    Chan MR; Young HN; Becker YT; Yevzlin AS
    Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.